Skip to content
2000
Volume 23, Issue 11
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Antimitotics binding at the colchicine site of tubulin are important antitumour and vascular disrupting agents. Pyridines and azines are privileged scaffolds in medicinal chemistry and in recent years many colchicine site ligands (CSL) have incorporated them into their structures with the aim of improving their pharmacokinetic and pharmacodynamics properties. CSL have been classified according to their chemical structures and the chemical structures of the pyridine and azine containing antimitotic compounds are described. The designed principles behind the structural modifications and the achieved effect on the biological activity upon inclusion of these heterocycles are also discussed. Lessons from the achievements and failures have been extracted and future perspectives delineated.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986732311160420104823
2016-04-01
2025-06-23
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986732311160420104823
Loading

  • Article Type:
    Research Article
Keyword(s): antimitotics; antitumour; azines; colchicine; drug design; Pyridine; tubulin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test